A Tumor Growth Inhibition Model Based on M‐Protein Levels in Subjects With Relapsed/Refractory Multiple Myeloma Following Single‐Agent Carfilzomib Use

Change in tumor size estimated using longitudinal tumor growth inhibition (TGI) modeling is an early predictive biomarker of clinical outcomes for multiple cancer types. We present the application of TGI modeling for subjects with multiple myeloma (MM). Longitudinal time course changes in M‐protein...

Descripción completa

Detalles Bibliográficos
Autores principales: Jonsson, F, Ou, Y, Claret, L, Siegel, D, Jagannath, S, Vij, R, Badros, A, Aggarwal, S, Bruno, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759707/
https://www.ncbi.nlm.nih.gov/pubmed/26904385
http://dx.doi.org/10.1002/psp4.12044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4759707/
https://www.ncbi.nlm.nih.gov/pubmed/26904385
http://dx.doi.org/10.1002/psp4.12044

Ejemplares similares